Review of the Australian Brain Cancer Mission
Friday 16 February 2024
“The collaboration between the Australian Government and Mission Funding Partners has been described as a ‘game-changer’ for children with brain cancer, transforming ANZCHOG’s capacity and capability to fund novel and innovative quality research and translate this research into better outcomes for children through access to clinical trials.”
Review of the Australian Brain Cancer Mission
We’re proud to share the fantastic commendation ANZCHOG received in the review of the Australian Brain Cancer Mission (ABCM), published August 2023.
The ABCM was announced in 2017 to provide a dedicated and substantial financial commitment to brain cancer research in Australia to better resource and coordinate efforts to address long standing poor survival and survivorship outcomes. Half way into the 10-year plan, the recent independent review assessed whether investments made through the Medical Research Future Fund (MRFF) aligned with objectives set out in the ABCM Roadmap and whether investments have made any achievements.
The review stated that investments in national infrastructure to support Australians accessing clinical trials, such as that of ANZCHOG, were well aligned with a role for the Australian Government.
Funding provided to ANZCHOG under the ABCM has enabled the opening of 11 paediatric brain cancer clinical trials in Australia, well-exceeding the original target of five. The review highlighted ANZCHOG’s ability to capitalise on opportunities for trial involvement as they arise, therefore enhancing Australian capacity in relation to paediatric clinical trial activity. ANZCHOG was also applauded for its ability to rapidly activate international clinical trials for Australian children.
ANZCHOG is a non-profit organisation committed to ensuring Australian and New Zealand children receive world-class cancer care. We are the peak professional body for paediatric oncologists and health professionals who care for children with cancer, spearheading national initiatives to enhance clinical care through communication, research, networking and education. We are also the national cooperative clinical trials group for childhood cancer, actively working with trial consortia around the globe to ensure Australian and New Zealand children have the opportunity to access the latest promising cancer treatments.
